Picture of Thermogenesis Holdings logo

THMO — Thermogenesis Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyHighly SpeculativeMicro Cap

Cesca Therapeutics surges on Canada's approval for co's cord blood processing system

** Shares of drug developer  KOOL.O  rise 23% to $3.43     
    ** Co says its subsidiary ThermoGenesis Corp received Health
Canada approval of its next-generation AXP II system for cord
blood processing  urn:newsml:reuters.com:*:nPn3RLKRa
    ** AXP II was cleared by the FDA in Nov. 2018    
    ** The product provides automated, rapid and reproducible
harvesting of stem cells from collected units of umbilical cord
blood and is used by cord blood banks 
    ** Up to Monday's close, stock had fallen 47.3% over the
past year

 (Reporting by Tamara Mathias in Bengaluru)
 ((Tamara.Mathias@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 1208; Reuters Messaging:
tamara.mathias.thomsonreuters.com@reuters.net))

Recent news on Thermogenesis Holdings

See all news